Deutetrabenazine
Brand name: Austedo
Rank #45 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$404.1M
Total Cost
60,532
Total Claims
$404.1M
Total Cost
2,499
Prescribers
$6,676
Cost per Claim
655
Beneficiaries
60,971
30-Day Fills
$162K
Avg Cost/Provider
24
Avg Claims/Provider
Share of Medicare Part D Spending
0.15%
of total Medicare Part D spending
$404.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $404.1M total
🔎 Data Overview
Ranked #45 out of 500 drugs tracked by total cost. Deutetrabenazine represents a significant portion of Medicare drug spending.
At $6,676 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $161,704 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $616,942 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Deutetrabenazine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Robert Morton | Psychiatry | Ada, OK | 557 | $4.0M |
| 2 | Victor Sung | Neurology | Birmingham, AL | 184 | $2.5M |
| 3 | Malcolm Duncan | Nurse Practitioner | Austin, TX | 237 | $1.5M |
| 4 | Angie-Kolleen Tan | Nurse Practitioner | Pacoima, CA | 129 | $1.5M |
| 5 | Bradleigh Pfitzer | Nurse Practitioner | Birmingham, AL | 171 | $1.4M |
| 6 | Marissa Dean | Neurology | Birmingham, AL | 163 | $1.3M |
| 7 | Jody Corey-Bloom | Neurology | La Jolla, CA | 150 | $1.3M |
| 8 | Robert Olson | Psychiatry | Mankato, MN | 154 | $1.2M |
| 9 | Charles Kamen | Neurology | Las Vegas, NV | 84 | $1.2M |
| 10 | Kelly Andrzejewski | Neurology | Rochester, NY | 88 | $1.2M |
| 11 | Charles Lewis | Psychiatry | Little Rock, AR | 157 | $1.1M |
| 12 | Jimmie Mcadams | Psychiatry | Tulsa, OK | 88 | $1.1M |
| 13 | Maryrita Mallet | Psychiatry | Weatherford, TX | 142 | $1.1M |
| 14 | Danielle Englert Doggett | Neurology | Charlotte, NC | 95 | $1.1M |
| 15 | Robert Morton | Psychiatry | Ada, OK | 152 | $1.0M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 42 | Atorvastatin Calcium (Atorvastatin Calcium) | $444.6M | 30,263,929 |
| 43 | Osimertinib Mesylate (Tagrisso) | $436.5M | 25,273 |
| 44 | Levothyroxine Sodium (Levothyroxine Sodium) | $435.3M | 20,209,418 |
| 45 | Deutetrabenazine (Austedo) | $404.1M | 60,532 |
| 46 | Linagliptin (Tradjenta) | $403.8M | 519,439 |
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
| 48 | Insulin Detemir (Levemir Flexpen) | $376.5M | 548,216 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology